Skip to main content

Open Access Release of anti-inflammatory drugs from a silicone elastomer matrix system

Download Article:
 Download
(PDF 202.32421875 kb)
 
The focus of the current study was to overcome the obstacles to incorporating non-steroidal anti-inflammatory drugs (NSAIDs) into a medical silicone elastomer and to investigate how the physicochemical properties of the drugs affect the curing process and drug release. Five representative NSAIDs were selected with different molecular weights and physicochemical properties. Silicone blends with 1% (w/w) drug in the sodium salt form could be obtained in a fully cured medical elastomer matrix whereas drugs in various other salt forms or the free acid form interfered with the curing process. The release rate was mainly dependent on the solubility in the drug-salt elastomer matrix, with ibuprofen sodium showing the fastest rate. These results indicate that inclusion of the NSAID salts in the silicone matrix does not change the microstructure or the permeability of the silicone matrix, and channel formation is minimal. The properties of NSAID-containing silicone blends are compatible with processes used for the manufacture of medical devices from silicone such as silicone stents or catheters, and could therefore be considered for such devices to reduce inflammation at the site of an implant and also for local delivery.
No References for this article.
No Supplementary Data.
No Data/Media
No Metrics

Document Type: Research Article

Affiliations: 1: Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland 2: Össur hf., Reykjavik, Iceland 3: Faculty of Pharmaceutical Sciences, University of Iceland, Hofsvallagata 53, Reykjavik, IS-107, Iceland, Iceland, Email: [email protected]

Publication date: 2009-01-01

More about this publication?
  • Pharmazie is a leading journal in the field of pharmaceutical sciences. As a peer-reviewed scientific journal, Pharmazie is regularly indexed in the relevant databases like Web of science, Journal Citation Reports and many others. The journal is open for submissions from the whole spectrum of pharnaceutical sciences including Pharmaceutical Chemistry, Experimental and Clinical Pharmacology, Drug Analysis, Pharmaceutics, Pharmaceutical Biology, Clinical Pharmacy etc.
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more